NEWS - Porosome Therapeutics, Inc.

State of Science at Porosome Therapeutics, Inc.

Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)

Porosome Therapeutics Inc, is proud to announce that Company Chairman Prof. Bhanu P. Jena delivered the Commencement Keynote Address to the 2024 Graduating Medical Class at Wayne State University on 6th June, 2024.

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena presents Public Lecture entitled: “A Humbling Journey Through Science”

Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena recognized with the 2024 “Lipid Science Prize”

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Discovery Underlying Porosome Therapeutics, Inc. Continues to Receive Global Recognition

A Patient-Centric Approach Built On The Porosome

Cystic Fibrosis Rescued by Reprogramming the Cell’s Secretory Machinery

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint

Porosome Therapeutics Announces Groundbreaking Approach to Advance Diabetes Treatment